Tundra Space

Tundra Space

Clinical Research Directory

Browse clinical research sites, groups, and studies.

Back to Studies
RECRUITING
NCT03651518
PHASE2

Personalized Therapies in Inflammatory Complex Disease

Sponsor: Assistance Publique - Hôpitaux de Paris

View on ClinicalTrials.gov

Summary

Inflammatory diseases may display atypical features making such patients impossible to classify. Management of these cases in daily practice cannot rely on the results of clinical trials nor on guidelines. DNA and RNA mapping have become major tools to understand and sometimes direct the treatment strategy in oncology. This study aims to test whether a precise analysis of molecular pathways in inflammatory, non classified diseases, can constitute a predictive tool of therapeutic efficiency

Official title: Personalized Targeted Therapies in Inflammatory Complex Multi Organ Disease

Key Details

Gender

All

Age Range

18 Years - Any

Study Type

INTERVENTIONAL

Enrollment

32

Start Date

2020-10-20

Completion Date

2025-11

Last Updated

2025-11-20

Healthy Volunteers

No

Interventions

DRUG

Kineret

100 mg, once/day sc 6 months

DRUG

Humira

40 mg/15 days sc 6 months

DRUG

Stelara

45 mg/12 weeks sc, 6 months

DRUG

Cosentyx

300mg sc every week for 1 month, then 300 mg/month sc for 5 months

DRUG

Roactemra

480 mg/perf/4 weeks 6 months

DRUG

Rituximab

2 sessions of 1000 mg at inclusion and 15 days after inclusion

Locations (1)

Hôpital Cochin

Paris, France